BridgeMD
New treatment option for Surgical Site Infection (SSI)
Official title A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
ClinicalTrials.gov ID: NCT07378683
What this study is testing
- What it's testing
- 1. Study Background For patients undergoing brain or spinal tumor surgery, postoperative surgical wound infection (known as "surgical site infection," SSI) is a recognized risk.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients with a pathologically confirmed primary or metastatic central nervous system (brain or spinal) tumor.
- Scheduled for elective craniotomy or spinal tumor resection surgery.
- Age ≥ 18 years.
- Expected survival \> 3 months, and able/willing to comply with postoperative follow-up.
- Voluntary participation and provision of written informed consent.
You likely can't join if
- Presence of active systemic or local surgical site infection before surgery.
- Use of therapeutic antibiotics for any reason within 72 hours prior to surgery.
- Concurrent severe immunosuppressive conditions, or chronic use of high-dose immunosuppressants.
- Pregnancy or lactation.
- Known contraindications or severe allergy to the antibiotics planned for use in the study.
- Any other condition that, in the investigator's judgment, may affect study participation or outcome assessment.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, PUMC, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, PUMC, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.